Ascentage Pharma Group International (HKG: 6855)
Hong Kong
· Delayed Price · Currency is HKD 41.05
-3.15 (-7.13%)
Nov 13, 2024, 4:08 PM HKT
Ascentage Pharma Group International Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Cash & Equivalents | 1,100 | 1,094 | 1,492 | 1,744 | 1,024 | 882.46 | Upgrade
|
| Short-Term Investments | - | 6.56 | 11.91 | 4.15 | 3.03 | 2.6 | Upgrade
|
| Cash & Short-Term Investments | 1,100 | 1,100 | 1,504 | 1,748 | 1,027 | 885.06 | Upgrade
|
| Cash Growth | -30.43% | -26.84% | -13.95% | 70.13% | 16.09% | -9.05% | Upgrade
|
| Accounts Receivable | 743.52 | 145.89 | 54.36 | 53.97 | - | - | Upgrade
|
| Other Receivables | - | 17.65 | 7.13 | 22.48 | 13.37 | 2.53 | Upgrade
|
| Receivables | 743.52 | 163.54 | 61.49 | 76.45 | 13.37 | 2.53 | Upgrade
|
| Inventory | 10.72 | 16.17 | 9.45 | 3.93 | - | - | Upgrade
|
| Prepaid Expenses | - | - | - | - | 38.25 | 21.52 | Upgrade
|
| Other Current Assets | 109.29 | 64.08 | 61.41 | 56.93 | - | - | Upgrade
|
| Total Current Assets | 1,964 | 1,344 | 1,636 | 1,885 | 1,079 | 909.11 | Upgrade
|
| Property, Plant & Equipment | 931.18 | 957.07 | 648.72 | 844.37 | 477 | 142.29 | Upgrade
|
| Long-Term Investments | 33.2 | 18.95 | 18.53 | 27.85 | 31.77 | 32.19 | Upgrade
|
| Goodwill | 24.69 | 24.69 | 24.69 | 24.69 | 24.69 | 24.69 | Upgrade
|
| Other Intangible Assets | 79.78 | 85.45 | 84.3 | 60.41 | 66.41 | 72.19 | Upgrade
|
| Long-Term Deferred Tax Assets | 55.07 | 59.84 | 54.29 | 51.65 | - | - | Upgrade
|
| Other Long-Term Assets | 19.3 | 10.22 | 363.23 | 45.81 | 52.12 | 24.58 | Upgrade
|
| Total Assets | 3,107 | 2,500 | 2,830 | 2,940 | 1,731 | 1,205 | Upgrade
|
| Accounts Payable | 83.08 | 72.45 | 95.56 | 70.86 | 23.36 | 13.08 | Upgrade
|
| Accrued Expenses | - | 125.68 | 120.65 | 75.32 | 60.58 | 91.76 | Upgrade
|
| Short-Term Debt | 120 | 120 | 139.9 | - | 30 | 85 | Upgrade
|
| Current Portion of Long-Term Debt | 600.1 | 486.65 | 370.41 | 39.8 | 14.75 | - | Upgrade
|
| Current Portion of Leases | 9.45 | 9.76 | 8.08 | 9.65 | 5.81 | 7.19 | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | 3.56 | - | Upgrade
|
| Current Unearned Revenue | 37.49 | 38.41 | 24.35 | 24.36 | 0.04 | 0.05 | Upgrade
|
| Other Current Liabilities | 215.24 | 81.24 | 122.21 | 141.12 | 138.05 | 4.98 | Upgrade
|
| Total Current Liabilities | 1,065 | 934.17 | 881.15 | 361.11 | 276.15 | 202.06 | Upgrade
|
| Long-Term Debt | 959.14 | 1,166 | 1,265 | 1,027 | 473.06 | - | Upgrade
|
| Long-Term Leases | 11.41 | 12.92 | 9.14 | 8.25 | 6.08 | 9.21 | Upgrade
|
| Long-Term Unearned Revenue | 270.07 | 287.55 | 218.63 | 243.28 | 40.21 | 35.1 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 5.85 | 10.55 | 12.15 | 13.75 | 15.36 | 16.96 | Upgrade
|
| Other Long-Term Liabilities | 18.8 | 18.3 | 35.33 | 52.34 | 73.57 | 51.25 | Upgrade
|
| Total Liabilities | 2,331 | 2,430 | 2,422 | 1,705 | 884.42 | 314.58 | Upgrade
|
| Common Stock | 0.21 | 0.2 | 0.18 | 0.18 | 0.15 | 0.14 | Upgrade
|
| Additional Paid-In Capital | 6,490 | 5,951 | 5,393 | 5,342 | 4,130 | 3,454 | Upgrade
|
| Retained Earnings | -5,202 | -5,365 | -4,439 | -3,557 | -2,774 | -2,097 | Upgrade
|
| Treasury Stock | -19.82 | -21.35 | -26.55 | -0 | -0 | -0 | Upgrade
|
| Comprehensive Income & Other | -501.79 | -504.46 | -518.51 | -550.95 | -509.81 | -467.5 | Upgrade
|
| Total Common Equity | 766.4 | 60.42 | 408.66 | 1,235 | 846.62 | 890.48 | Upgrade
|
| Minority Interest | 10.04 | 10.22 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 776.44 | 70.63 | 408.66 | 1,235 | 846.62 | 890.48 | Upgrade
|
| Total Liabilities & Equity | 3,107 | 2,500 | 2,830 | 2,940 | 1,731 | 1,205 | Upgrade
|
| Total Debt | 1,700 | 1,796 | 1,793 | 1,084 | 529.7 | 101.41 | Upgrade
|
| Net Cash (Debt) | -599.78 | -695.21 | -288.58 | 663.68 | 497.73 | 783.65 | Upgrade
|
| Net Cash Growth | - | - | - | 33.34% | -36.49% | - | Upgrade
|
| Net Cash Per Share | -2.06 | -2.46 | -1.09 | 2.61 | 2.31 | 6.71 | Upgrade
|
| Filing Date Shares Outstanding | 309.38 | 290.05 | 259.91 | 257.61 | 220.77 | 203.63 | Upgrade
|
| Total Common Shares Outstanding | 309.38 | 290.05 | 259.91 | 257.61 | 220.77 | 203.63 | Upgrade
|
| Working Capital | 898.49 | 410.01 | 755.34 | 1,524 | 802.9 | 707.04 | Upgrade
|
| Book Value Per Share | 2.48 | 0.21 | 1.57 | 4.79 | 3.83 | 4.37 | Upgrade
|
| Tangible Book Value | 661.93 | -49.72 | 299.66 | 1,150 | 755.52 | 793.59 | Upgrade
|
| Tangible Book Value Per Share | 2.14 | -0.17 | 1.15 | 4.46 | 3.42 | 3.90 | Upgrade
|
| Buildings | - | 834.91 | 470.22 | 406.95 | - | - | Upgrade
|
| Machinery | - | 179.87 | 155.21 | 60.98 | 51.52 | 47.15 | Upgrade
|
| Construction In Progress | - | 12.65 | 39.49 | 362.86 | 406.56 | 60.04 | Upgrade
|
| Leasehold Improvements | - | 29.22 | 7.74 | 8.14 | 11.6 | 11.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.